1667 related articles for article (PubMed ID: 27487139)
21. Long Noncoding RNA Expression Signatures of Colon Cancer Based on the ceRNA Network and Their Prognostic Value.
Cheng Y; Geng L; Wang K; Sun J; Xu W; Gong S; Zhu Y
Dis Markers; 2019; 2019():7636757. PubMed ID: 30984308
[TBL] [Abstract][Full Text] [Related]
22. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Li F; Huang C; Li Q; Wu X
Med Sci Monit; 2018 Jan; 24():37-49. PubMed ID: 29295970
[TBL] [Abstract][Full Text] [Related]
23. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
[TBL] [Abstract][Full Text] [Related]
24. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
[TBL] [Abstract][Full Text] [Related]
26. Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Li F; Li Q; Wu X
PLoS One; 2018; 13(2):e0192494. PubMed ID: 29420609
[TBL] [Abstract][Full Text] [Related]
27. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
28. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
29. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
[TBL] [Abstract][Full Text] [Related]
30. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Qi M; Yu B; Yu H; Li F
Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
[TBL] [Abstract][Full Text] [Related]
32. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
33. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.
Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W
Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410
[TBL] [Abstract][Full Text] [Related]
34. Identification of Potential Prostate Cancer-Related Pseudogenes Based on Competitive Endogenous RNA Network Hypothesis.
Jiang T; Guo J; Hu Z; Zhao M; Gu Z; Miao S
Med Sci Monit; 2018 Jun; 24():4213-4239. PubMed ID: 29923546
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
37. Identification of functional lncRNAs in atrial fibrillation by integrative analysis of the lncRNA-mRNA network based on competing endogenous RNAs hypothesis.
Qian C; Li H; Chang D; Wei B; Wang Y
J Cell Physiol; 2019 Jul; 234(7):11620-11630. PubMed ID: 30478836
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Wang H; Niu L; Jiang S; Zhai J; Wang P; Kong F; Jin X
Oncotarget; 2016 Dec; 7(52):86174-86185. PubMed ID: 27863388
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MEG3 play an important role in osteosarcoma development through sponging microRNAs.
Jiang M; Wang YR; Xu N; Zhou L; An Q
J Cell Biochem; 2019 Apr; 120(4):5151-5159. PubMed ID: 30324678
[TBL] [Abstract][Full Text] [Related]
40. Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
Gao H; Chen X; Shang Z; Niu Y
Oncol Rep; 2018 Aug; 40(2):959-967. PubMed ID: 29901101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]